Spruce Biosciences to present MPS IIIB natural history data

Spruce Biosciences said data from its Study 250-902 natural history trial in pediatric MPS IIIB will be presented at the Child Neurology Society annual meeting on Oct. 15 in Montréal. The poster will be available on the company website after the presentation.